can you switch between tirzepatide and semaglutide vs. for Weight Loss How To Safely Transition From

Wegovy is prescribed for adults with: A BMI of 30 or higher (obesity classification) A BMI of 27 or higher with weight-related health conditions (hypertension, type 2 diabetes, heart disease) A history of weight regain after previous weight loss attempts Clinical Effectiveness Studies show Wegovy users lose an average of 15-22% of their body weight over 68 weeks

10.1002/stem.3101 Stem Cells 131 WangL.AzadN.KongkaneramitL.ChenF.LuY.JiangB.-H.et al (2008)

We believe in longer, unhurried visits, so you feel heard, supported, and informed at every step

How PlexusDx Tirzepatide Injections Support Consistent Weekly Dosing PlexusDx provides tirzepatide from licensed 503A compounding pharmacies, ensuring each dose is prepared to exact specifications for weekly injection schedules

It can also be used in children 10 years of age and older